Pratley RE, Aroda VR, Lingvay I, Ldemann J, Andreassen C, Navarria A, et al
Association between osteoarthritis and cardiovascular disease: systematic review and meta-analysis
Nov 2023 - The FDA's approval of Eli Lillys Zepbound (tirzepatide) represents a significant advancement in obesity treatment, as it uniquely targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors
GLP-1 is an endogenous hormone with 30 amino acids that is mainly derived from the preproglucagon molecule in enteroendocrine L-cells of the gastrointestinal tract (Bae and Song, 2017
In comparison, Nalena offers the same medication at a consistently lower monthly price pointroughly $150 lessmaking it significantly more cost-effective over time , particularly for users planning to stay on treatment for several months or longer
Studies from the Cleveland Clinic show that mindful eating exercises like this significantly reduce overeating after weight-loss therapy